Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy

BACKGROUND/AIMS: Second-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma (PDAC) that progresses following gemcitabine-based treatment has not been established. This study aimed to investigate the efficacy and safety of second-line combination chemotherapy with capecitabin...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Gut Liver
Glavni autori: Chung, Kwang Hyun, Ryu, Ji Kon, Son, Jun Hyuk, Lee, Jae Woo, Jang, Dong Kee, Lee, Sang Hyub, Kim, Yong-Tae
Format: Artigo
Jezik:Inglês
Izdano: Editorial Office of Gut and Liver 2017
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347656/
https://ncbi.nlm.nih.gov/pubmed/27965478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16307
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items